» Articles » PMID: 12818166

B7S1, a Novel B7 Family Member That Negatively Regulates T Cell Activation

Overview
Journal Immunity
Publisher Cell Press
Date 2003 Jun 24
PMID 12818166
Citations 200
Authors
Affiliations
Soon will be listed here.
Abstract

T cell activation by antigen-presenting cells (APC) is regulated by positive and negative costimulatory molecules in the B7 family. Here we describe a novel addition in this family, designated as B7S1, which is uniquely anchored to the cell membrane via a GPI linkage. B7S1 is expressed on professional APC and widely distributed in nonlymphoid tissues. A soluble B7S1-Ig fusion protein binds to activated but not naive T cells. B7S1-Ig inhibits T cell activation and IL-2 production. A monoclonal antibody that blocks binding of B7S1 to its receptor enhances T cell proliferation in vitro and exacerbates experimental autoimmune encephalomyelitis in vivo. This study identifies a novel negative regulator of T cell activation and further reveals complex costimulatory regulation of immune responses.

Citing Articles

Clinical Effect of Treatment with Metformin for Type 2 Diabetes on Non-Small Cell Lung Cancer Patients Undergoing Immunotherapy: A Retrospective Study.

Wang Y, Sun Y, Hu J, Ma H Int J Gen Med. 2025; 17:6595-6604.

PMID: 39759894 PMC: 11699848. DOI: 10.2147/IJGM.S495449.


CD8 T cell exhaustion in the tumor microenvironment of breast cancer.

Xie H, Xi X, Lei T, Liu H, Xia Z Front Immunol. 2024; 15:1507283.

PMID: 39717767 PMC: 11663851. DOI: 10.3389/fimmu.2024.1507283.


The immune checkpoint molecule B7-H4 regulates β-cell mass and insulin secretion by modulating cholesterol metabolism through Stat5 signalling.

Xia F, Zhang Z, Qian Z, Fang X, Wang J, Wang Y Mol Metab. 2024; 91():102069.

PMID: 39571901 PMC: 11636127. DOI: 10.1016/j.molmet.2024.102069.


The role of B7-H4 in ovarian cancer immunotherapy: current status, challenges, and perspectives.

Zhou L, Duan Y, Fu K, Zhang M, Li K, Yin R Front Immunol. 2024; 15:1426050.

PMID: 39267740 PMC: 11390377. DOI: 10.3389/fimmu.2024.1426050.


Tuning Immune-Cold Tumor by Suppressing USP10/B7-H4 Proteolytic Axis Reinvigorates Therapeutic Efficacy of ADCs.

Zeng L, Zhu Y, Cui X, Chi J, Uddin A, Zhou Z Adv Sci (Weinh). 2024; 11(40):e2400757.

PMID: 39206932 PMC: 11516061. DOI: 10.1002/advs.202400757.